Tumor-infiltrating B cells and plasma cells influence early-stage lung cancer biology, immunotherapy responses

Through extensive single-cell analysis, researchers at The University of Texas MD Anderson Cancer Center have created a spatial map of tumor-infiltrating B cells and plasma cells in early-stage lung cancers,

How a common antibiotic fuels bacterial resistance

Antibiotics are supposed to wipe out bacteria, yet the drugs can sometimes hand microbes an unexpected advantage. A new study from Rutgers Health shows that ciprofloxacin, a staple treatment for

Biomarker may predict immunotherapy response in liver cancer

It may soon be possible to determine which patients with a type of liver cancer called hepatocellular carcinoma would benefit from immunotherapy, according to a preclinical study by Weill Cornell